This site is intended for healthcare professionals

Sign in
Go to /sign-in page

You can view 5 more pages before signing in

Vasoconstrictor therapy for upper GI bleeding

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

Vasoconstrictor therapy aims to restrict portal inflow by constricting the splanchnic arteries. It is employed before endoscopy and sclerotherapy, as an adjunct to the latter or if sclerotherapy has failed to control variceal bleeding.

Specific agents include:

  • vasopressin
  • terlipressin - a synthetic analogue of vasopressin
  • octreotide - a somatostatin analogue, which has relatively few adverse effects
  • somatostatin

NICE suggest that:

  • terlipressin should be offered to patients with suspected variceal bleeding at presentation. Stop treatment after definitive haemostasis has been achieved, or after 5 days, unless there is another indication for its use

Reference:

Related pages

Create an account to add page annotations

Create a free account

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.